Name:
N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic acid dimethyl ester hydrochloride (Related Reference)
Molecular Formula:
C40H50N8O6.2(HCl)
CAS Registry Number:
1009119-65-6
*The following content is generated by AI and is for reference only.
Overview
Daclatasvir is a potent direct-acting antiviral (DAA) of the NS5A inhibitor class. Synthesized via advanced organic chemistry, its molecular formula is C29H31F3N4O3 with CAS No. 850140-76-4.
Application
- Hepatitis C treatment: Combined with sofosbuvir for genotype 1 and 3 infections.
- Pharmaceutical manufacturing: Bulk API production for generic formulations.
- Clinical trials: Investigational use in combination therapies for resistant strains.
Precautions
Strictly contraindicated in severe hepatic impairment without specific regimen adjustments. Requires storage below 25°C in dry conditions. Handling demands PPE to prevent dermal absorption and respiratory exposure during bulk processing.